kitio.aiEmedgene vs NetraMark
A side-by-side look at pricing plans, free tiers, features, pros and cons, updated for 2026. Emedgene starts at See pricing page and NetraMark starts at See pricing page. Check both pricing pages for current plans.
At a glance
Best for
Pricing model
Starting price
Free plan
Made by
Based in
Rating
Key features
- Variant prioritisation
- Explainable AI evidence
- Rare disease workflows
- Automated case review
- Illumina DRAGEN pairing
- Patient subgroup discovery
- Causal variable detection
- Placebo response analysis
- Dose optimization insights
- Inclusion criteria design
| Feature | Emedgene | NetraMark |
|---|---|---|
| Best for | Explainable AI for germline variant interpretation in rare disease | AI that finds responsive patient groups to improve clinical trial design |
| Category | Legal, finance & HR | Legal, finance & HR |
| Pricing model | Paid | Paid |
| Starting price | See pricing page | See pricing page |
| Free plan | No | No |
| Made by | Illumina | NetraMark Holdings |
| Based in | United States | Canada |
| Rating | No ratings yet | No ratings yet |
| Key features |
|
|
Pricing compared
Emedgene starts at See pricing page and NetraMark starts at See pricing page. Check both pricing pages for current plans.
Free plan
Cheapest paid plan
Top plan
Free trial
Prices in USD, checked Nov 5, 2026 or later. Plans change often, so confirm on each tool's site before you buy.
Pros and cons
Emedgene
- Shows the evidence behind each ranked variant
- Backed by a major sequencing company
- Cuts manual variant curation time
- No public pricing
- Aimed at genomics labs, not individuals
- Product page buried in a large corporate site
NetraMark
- Explains why patient groups respond
- Works on existing trial datasets
- Published research behind the method
- Enterprise engagements only
- No public pricing
- Narrow focus on clinical development
Which one should you choose?
Choose Emedgene if you want:
- Shows the evidence behind each ranked variant
- Backed by a major sequencing company
- Cuts manual variant curation time
Watch out: no public pricing.
Choose NetraMark if you want:
- Explains why patient groups respond
- Works on existing trial datasets
- Published research behind the method
Watch out: enterprise engagements only.
Emedgene vs NetraMark FAQ
What is the difference between Emedgene and NetraMark?
Emedgene: Explainable AI for germline variant interpretation in rare disease. NetraMark: AI that finds responsive patient groups to improve clinical trial design. Both are legal, finance & hr tools.
Is Emedgene or NetraMark cheaper?
Emedgene starts at See pricing page and NetraMark starts at See pricing page. Check both pricing pages for current plans.
Do Emedgene and NetraMark have free plans?
Emedgene: No. NetraMark: No.
Who makes Emedgene?
Emedgene is made by Illumina, based in United States.
Who makes NetraMark?
NetraMark is made by NetraMark Holdings, based in Canada.
Which should I choose, Emedgene or NetraMark?
Choose Emedgene if you value shows the evidence behind each ranked variant and backed by a major sequencing company. Choose NetraMark if you value explains why patient groups respond and works on existing trial datasets.